"Third-generation" Synergy and Cre8 DES show promise TheHeart.Org Dr Ian Meredith (Monash Medical Center, Melbourne, Australia) presented results from the first-in-human EVOLVE trial, testing the everolimus-eluting Synergy stent (Boston Scientific), which uses an ultrathin bioabsorbable polymer coating on the ... EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and ... Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and ... |
